Have Questions?
            Call 877-257-0042
Speak With a Real Person with Real Answers  

    Apply Online Now . . Be Preapproved Today!

 LOWEST RATES - LOWEST COSTS - FAST CLOSING

 
 

Latest News

AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal

A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock ExchangeThe deal -- the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline -- confounds expectations that Pharmacyclics would sell out to Johnson & Johnson . AbbVie will pay $261.25 per share in cash and stock, a 13 percent premium to Pharmacyclics stock's closing price on Wednesday. AbbVie failed last October to buy Dublin-based Shire Plc for $55 billion after the United States took steps to deter such tax-lowering deals. Deutsche Bank analyst Robyn Karnauskas said the deal was positive for AbbVie as Pharmacyclics' blood cancer treatment Imbruvica would diversify the business beyond Humira.


                   
     PRIVATE BANK LOANS are available
 
Interest Rates Start at 7.99%
 
If you cannot qualify for any of our loan programs then a Non-Traditional Mortgage could be the solution for you
 
  • One Day out of Short Sale or Foreclosure 
  • 20% Down Payment Required          
  • No Prepayment Penalty - Pay off Anytime
 
Fast Closings for Investment, Primary or Second Homes

Call For More Information (877) 257-0042

Or Apply Online Now and Be Approved Today

 
                                                

 


 
Need More Information?

*
 
 
 
*
 
 
*